AVILIVE obtains the novel crystalline form of picoxystrobin patent license from ALBAUGH for strategic collaboration.

Hangzhou,China, July 1st 2026-Zhejiang Avilive is pleased to announce the signing of patent licensing agreement with Albaugh Asia Pacific Limited to license Albaugh’s Patent in China on the Novel Crystalline form of Picoxystrobin, Under the agreement, Avilive enables technical-grade manufacturing and formulation development and producing, and offer the prodcuts to global markets. the patent is valid in China Until 2037-01-18.

浙江埃森化學有限公司獲美愛保集團啶氧菌酯新型晶型專利授權以開展戰略合作

2026 年 7 月 1 日，中國東陽 —— 浙江埃森化學有限公司欣然宣布，已與美愛保集團簽署專利許可協議，取得美愛保集團在中國擁有的啶氧菌酯新型晶型專利授權。根據協議約定，浙江埃森化學有限公司可開展該產品原藥生產與制劑研發生產工作，并面向全球市場供應相關產品。該專利在中國境內有效期至 2037 年 1 月 18 日。